CI
Cepton, Inc. (CPTN)·Q1 2024 Earnings Summary
Executive Summary
- Q1 2024 revenue was $1.95M (product $1.14M; development $0.81M), up 31% YoY, with GAAP net loss of $6.83M (−$0.43 per share) and Non-GAAP net loss of $8.34M (−$0.52 per share) .
- The quarter featured a new multi‑year OEM series production award for near‑range lidar with Koito and a $10M engineering services (NRE) contract to be recognized in Q2 2024; management expects to be cash flow positive in Q2 2024, a first for the company and (they believe) the lidar industry .
- A $4.0M cash recovery from the canceled GM program was recorded as a gain in Q1 (excluded from Non‑GAAP), strengthening liquidity (cash and cash equivalents $49.2M at 3/31/24) .
- FY 2024 outlook introduced: revenue $15–$25M and operating expenses below $50M, driven by Q2 NRE and additional potential development milestones; mix and timing across additional OEM programs explains the wide range .
What Went Well and What Went Wrong
What Went Well
- Secured a new series production award with a global OEM (near‑range lidar) and signed a $10M engineering services contract with Koito for Q2, indicating increased commercial traction and near‑term revenue visibility .
- Rapid progress on Ultra (next‑gen long‑range lidar): reached B‑sample ahead of plan, integrated MagnoSteer, and demonstrated to OEMs in the U.S., Europe, and Japan; customer feedback was “overwhelmingly positive” .
- Management expects positive cash flow in Q2 2024, citing the sizable NRE and early sample sales; “we expect to become cash flow positive this quarter for the first time in the company's history” .
What Went Wrong
- Sequential revenue decelerated from Q4 2023 ($4.95M) to Q1 2024 ($1.95M), reflecting lower product/development revenue quarter‑over‑quarter even as YoY growth remained positive .
- Automotive program dynamics remain elongated: high‑volume production revenue from the new award is typically 2.5–3.0 years ahead of SOP; near‑term visibility is more weighted to NRE/samples than mature production .
- Non‑GAAP net loss remained sizable at −$8.34M despite the $4.0M GM cost‑recovery gain (excluded from Non‑GAAP), underscoring ongoing investment and the early revenue scale of automotive lidar .
Financial Results
Segment revenue mix:
Selected operating KPIs:
Notes:
- Q1 2024 included a $4.0M GM project cancellation cost‑recovery gain (cash received) recorded in other income and excluded from Non‑GAAP results .
- Consensus estimates (revenue/EPS) from S&P Global were unavailable for CPTN this quarter; therefore, no estimate comparison is shown.
Guidance Changes
Rationale/Color:
- FY24 range reflects signed Q2 NRE and potential additional OEM program milestones; mix/timing uncertainty drives the breadth of the revenue range .
Earnings Call Themes & Trends
Management Commentary
- “We have successfully advanced the Ultra from its initial concept to the B sample stage… The feedback from these global showcases has been overwhelmingly positive.” — Jun Pei, CEO .
- “We expect to become cash flow positive this quarter for the first time in the company's history… Starting with revenue this quarter.” — Mitch Hourtienne, CCO (re: Q2 NRE and samples) .
- “We recorded a $4.0 million gain from cost recovery of the cancelled OEM project in the first quarter of 2024 and received a cash payment subsequently.” — Press Release ; confirmed as cash received in Q1 .
- “We’ve recently completed the final submission for an RFQ to a top 10 global automotive OEM… We’ve also made our first RFQ submission to a top 3 global automotive OEM.” — CCO .
Q&A Highlights
- $4M GM cost‑recovery was cash received in Q1 .
- New OEM award timeline: high‑volume production revenue typically 2.5–3.0 years pre‑SOP; Q2 will include development and sample revenues .
- NRE cadence: full $10M recognized in Q2 with additional development revenue expected in H2’24 (lumpy vs product) .
- FY24 revenue guide mix: a blend of NRE and product; range reflects timing/customer sign‑off across “2 or 3 other OEM projects” .
- Regulatory backdrop: recent AEB focus viewed as a “huge hallmark” for lidar adoption; technology becoming cost‑effective and integration‑ready .
- Strategic update: Koito proposal process ongoing; no additional details yet .
Estimates Context
- S&P Global consensus estimates for Q1 2024 (revenue/EPS) were unavailable for CPTN due to missing mapping in the SPGI dataset at time of retrieval, so we cannot provide a beat/miss analysis this quarter. Comparisons to estimates are therefore not shown.
Key Takeaways for Investors
- Near‑term revenue/CF catalyst: ~$10M Koito NRE recognized in Q2 and early sample sales; management expects Q2 2024 positive cash flow — a potential stock catalyst in a capital‑intensive vertical .
- Strategic traction: new multi‑year series production award (near‑range), with ongoing RFQs at Top‑10 and Top‑3 OEMs for long‑range and near‑range — expanding future production optionality .
- Liquidity cushion: $49.2M cash & equivalents at Q1‑end, bolstered by $4.0M cost‑recovery cash; runway supports execution through NRE‑heavy 2024 .
- FY24 setup: revenue guide $15–$25M and OpEx below $50M hinges on OEM milestones and mix; watch for additional development contracts and sample revenue in H2’24 .
- Technology leadership: Ultra B‑sample ahead of plan with MagnoSteer; multi‑continent demos show positive feedback — supports future sourcing outcomes .
- Policy tailwinds: increasing regulatory emphasis on AEB/safety features could accelerate lidar adoption — management views this as a structural tailwind .
- Strategic optionality: Koito’s ongoing proposal creates an overhang/upside scenario; any update could be a meaningful catalyst .